|
|
|||
| |||||||||||||||||||||||||||||||||||||
Oncologists tend, by nature and occupation, to be optimists, whereas pathologists are more inclined to be pessimists; to put it another way, oncologists are romantics, whereas pathologists are realists. Thus, oncologists point out that in the past few decades substantial progress has been made in the treatment of ovarian cancer, but pathologists, including me, note that the survival rate among patients with this disease has remained unchanged for the past quarter of a century. Both, of course, are right: five-year survival rates are incrementally, albeit slowly, increasing, and our basic understanding of the disease is rapidly evolving, but the survival
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |